Skip to main content

Table 1 General characteristics of study participants

From: Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

Variables

The study groups

P

Placebo (n = 20)

Melatonin + Mg (n = 22)

Melatonin (n = 21)

Mg (n = 21)

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Age (y)a

26.200 ± 5.72

28.22 ± 6.38

25.57 ± 4.99

25.57 ± 4.88

0.346

Family history of PCOSc

4 (20.00)

6 (27.30)

6 (28.60)

3 (14.30)

0.657

Irregular menstrual cyclesc

20 (95.00)

22 (100.00)

20 (95.20)

19 (90.50)

0.541

Weight (kg)a

 Before

69.600 ± 11.39

76.61 ± 10.89

72.65 ± 11.21

71.23 ± 8.55

0.172

 After

69.65 ± 11.26

76.02 ± 10.86

72.04 ± 11.28

70.61 ± 9.05

0.226

 P*

0.888

0.018

0.061

0.127

 

 Height (cm)a

160.60 ± 6.46

160.63 ± 4.94

159.76 ± 5.19

159.57 ± 6.77

0.905

BMI (kg/m2)a

 Before

26.94 ± 3.83

29.64 ± 3.71

28.40 ± 3.86

27.99 ± 3.22

0.128

 After

26.95 ± 3.72

29.41 ± 3.70

28.16 ± 3.83

27.74 ± 3.30

0.179

 P*

0.928

0.016

0.058

0.122

 

WC (cm)a

 Before

86.75 ± 7.23

92.00 ± 9.01

89.23 ± 8.37

86.14 ± 6.72

0.071

 After

86.85 ± 7.37

91.09 ± 8.68

88.61 ± 8.25

85.04 ± 6.49

0.077

 P*

0.755

0.008

0.039

0.017

 

 PAb

120.39 (49.50, 693.00)

153.10 (49.50, 925.00)

152.47 (49.50, 808.5)

135.12 (49.50, 694.00)

0.874

  1. Mg magnesium, BMI body mass index, WC waist circumference, PA physical activity
  2. P values based on One-Way ANOVA for continuous variables and χ2 for categorical variables
  3. P* values based on paired-samples t test
  4. aValues are Means ± SD
  5. bValues are Geometric Means (Min, Max)
  6. cValues are expressed as frequency (%)